Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preventive methylprednisolone for extracorporeal circulation-induced coagulation dysfunction
2010-020329-42Phase 4Completed
- Sponsor
- Policlinico di Bari
- Start
- Sep 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of methylprednisolone in coagulation defects, hyperfibrinolysis and perioperative bleeding (2 arms), sponsored by Policlinico di Bari. Primary endpoints: Blood loss, Blood transfusions and blood products and 22 more. Started Sep 2010; status: completed.
02
Drugs
methylprednisolone
03
Conditions
coagulation defectshyperfibrinolysisperioperative bleeding
Beyond the preview
Go deeper on 2010-020329-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020329-42.